EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Blocking β2-AR and Inhibiting COX-2: A Promising Approach to Suppress OSCC Development

Zeliu Huang, Laifeng Huang, Chong Zhang, Guosheng Chen, Huaming Mai

International Dental Journal · 2025

DOI: 10.1016/j.identj.2024.06.014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Dental Journal, 2025. Verfasst von Zeliu Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, College and Hospital of Stomatology, Guangxi Medical University, Nanning, Guangxi, China; Guangxi Key L…. Hauptthemen laut MEDLINE: Mouth Neoplasms, Carcinoma, Squamous Cell, Cyclooxygenase 2, Cyclooxygenase 2 Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangxi Zhuang Autonomous Region Health and Family Planning Commission, Natural Science Foundation of Guangxi Province, Guangxi Zhuang Region Health and Family Planning Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: β2-adrenergic receptor (β2-AR) and cyclooxygenase-2 (COX-2) are overexpressed in various malignant tumours including oral squamous cell carcinoma (OSCC), suggesting that they may contribute to the development of OSCC. This study aims to investigate the potential synergistic effect of β2-AR blockade and COX-2 inhibition on suppressing the development of OSCC. METHODS: Effects of blocking β2-AR and inhibiting COX-2 on migration and invasion of OSCC cells were detected by wound-healing assay and transwell invasion assay. Western blot and enzyme-linked immunosorbent assay (ELISA) were used to detect the expression of genes related to the progression of OSCC. In vivo, OSCC xenograft models were established to evaluate the effect of combined treatment on survival time, tumour size, and submandibular lymph node metastasis. Immunohistochemistry, Western blot, and ELISA were used to detect the expression of invasion and metastasis relative genes. RESULTS: In vitro, blocking β2-AR or inhibiting COX-2 alone could suppress invasion and metastasis of OSCC cells, and suppression with combined treatment was more significant. Expression of genes related to invasion and metastasis, including EGFR, TGF-β1, IL-1β, MMP2, and VEGFA, were downregulated significantly, especially in the combined treatment group. In vivo, the combined treatment could significantly prolong survival time in tumour-bearing mice and inhibit the growth of tumours. Furthermore, submandibular lymph node metastasis was less in the combined treatment group, and expression of the abovementioned genes was also downregulated. CONCLUSIONS: The combination of β2-AR blockade and COX-2 inhibition can significantly suppress the development of OSCC via downregulating EGFR, TGF-β1, IL-1β, MMP2, and VEGFA. Findings suggest that the combined use of a β2-AR blocker and a COX-2 inhibitor could be a promising adjuvant therapy in OSCC. Both drugs are commonly prescribed, and their safety and efficacy are well established. Their use in adjuvants in OSCC should therefore be promoted in clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsCarcinoma, Squamous CellCyclooxygenase 2Cyclooxygenase 2 InhibitorsAdrenergic beta-2 Receptor AntagonistsAnimalsHumansMiceCell Line, TumorReceptors, Adrenergic, beta-2Neoplasm InvasivenessCell MovementEnzyme-Linked Immunosorbent AssayBlotting, WesternMice, NudeMaleMice, Inbred BALB CErbB ReceptorsMatrix Metalloproteinase 2Lymphatic Metastasis

Stichwörter der Autor:innen

COX-2InvasionMetastasisOSCCβ2-AR

Substanzen

Cyclooxygenase 2Cyclooxygenase 2 InhibitorsAdrenergic beta-2 Receptor AntagonistsReceptors, Adrenergic, beta-2ErbB ReceptorsMatrix Metalloproteinase 2

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, College and Hospital of Stomatology, Guangxi Medical University, Nanning, Guangxi, China; Guangxi Key Laboratory of Oral and Maxillofacial Rehabilitation and Reconstruction,…

Förderung

  • Guangxi Zhuang Autonomous Region Health and Family Planning Commission
  • Natural Science Foundation of Guangxi Province
  • Guangxi Zhuang Region Health and Family Planning Commission
  • National Key Clinical Specialty Discipline Construction Program of China
  • National Natural Science Foundation of China

Zitieren

APA

Huang, Z., Huang, L., Zhang, C., Chen, G., & Mai, H. (2025). Blocking β2-AR and Inhibiting COX-2: A Promising Approach to Suppress OSCC Development. International Dental Journal. https://doi.org/10.1016/j.identj.2024.06.014

Vancouver

Huang Z, Huang L, Zhang C, Chen G, Mai H. Blocking β2-AR and Inhibiting COX-2: A Promising Approach to Suppress OSCC Development. International Dental Journal. 2025. doi:10.1016/j.identj.2024.06.014

BibTeX
@article{Huang2025,
  author = {Huang, Zeliu and Huang, Laifeng and Zhang, Chong and Chen, Guosheng and Mai, Huaming},
  title = {Blocking β2-AR and Inhibiting COX-2: A Promising Approach to Suppress OSCC Development},
  journal = {International Dental Journal},
  year = {2025},
  doi = {10.1016/j.identj.2024.06.014}
}
Kostenlos starten →